Amarin Commemorates National Triglycerides Day on March 28
Amarin would like to commend recognition of National Triglycerides Day by patient advocacy groups and professional societies from a variety of therapeutic areas who represent patients and healthcare professionals dedicated to improving and advancing patient care, including:
DiabetesSisters
Hormone Health Network
Triglycerides are a type of fat (lipid) found in the blood. The liver makes triglycerides. Many of the foods eaten contain triglycerides. After eating, any extra calories that the body doesn't need right away are converted into triglycerides. These fatty substances are stored in fat cells. They are later released and circulated through the bloodstream to be used as energy by cells. But, as with "bad" cholesterol (LDL-C), too much can be harmful. Most dietary fats are triglycerides.1 High triglycerides are associated with cardiovascular risk, even in people with well-controlled LDL-C.2, 3, 4, 5
Normal triglyceride levels are generally less than 150 mg/dL; borderline high levels are between 150 and 199 mg/dL; high levels are between 200 and 499 mg/dL; and very high levels are 500 mg/dL and over.1
Patients and healthcare professionals need to know about the hidden risks associated with high triglycerides. National Triglycerides Day is an important opportunity to encourage patients to learn more about their triglyceride levels and to take action towards living a healthy life, starting with talking to their healthcare professionals.
About Amarin
Availability of Other Information About Amarin
Investors and others should note that Amarin communicates with its investors and the public using the company website (http://www.amarincorp.com/), the investor relations website (http://investor.amarincorp.com/), including but not limited to investor presentations and investor FAQs,
References
1Cardiosmart.org. Very High Triglycerides. Available at: https://www.cardiosmart.org/Heart-Conditions/High-Cholesterol/High-Cholesterol-Home/Very-High-Triglycerides.
2 Budoff M. Triglycerides and triglyceride-rich lipoproteins in the causal pathway of cardiovascular disease. Am J Cardiol. 2016;118:138-145.
3 Toth PP, Granowitz C, Hull M, et al. High triglycerides increase cardiovascular events, medical costs, and resource utilization in a real-world analysis of statin-treated patients with high cardiovascular risk and well-controlled low-density lipoprotein cholesterol [abstract]. Circulation. 2017;136(suppl):A15187.
4 Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease - New insights from epidemiology, genetics, and biology. Circ Res. 2016;118:547-563.
5 Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease.
Amarin Contact Information
Investor Relations:
Investor Relations and Corporate Communications
In U.S.: +1 (908) 719-1315
investor.relations@amarincorp.com
Trout Group
In U.S.: +1 (646) 378-2992
lstern@troutgroup.com
Media Inquiries:
In U.S.: +1 (212) 583-2791
Kristie.kuhl@finnpartners.com
News Provided by Acquire Media